首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1620351

Aralelin 的全球市場規模：按類型、應用、地區、範圍和預測

Global Alarelin Market Size By Type, By Applications, By Geographic Scope And Forecast

出版日期: 2024年10月10日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

Aralelin 市場規模及預測

2024 年 Ararelin 市場規模為 26 億美元，預計到 2031 年將達到 57 億美元，2024-2031 年預測期間複合年增長率為 4.4%。Aralelin 主要用於臨床研究，以評估藥物在生殖和性研究中對動物體的影響。子宮內膜異位症盛行率的上升，加上醫療保健研究的不斷增加，正在推動 Ararelin 市場向前發展。Ararelin 的使用可能會引起一些副作用和其他醫療併發症，這可能會阻礙市場成長。預測期內的全球 Aralelin 市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球 Aralelin 市場定義

Aralelin 是一種釋放激素，也稱為促性腺激素。它是一種合成的 LH-RH 激動劑，在體外、體內和誘導排卵時的濃度均高於 LH-RH。它是一種常用於治療子宮內膜異位症和子宮肌瘤的藥物。Aralelin主要用於臨床研究，研究藥物對動物體的影響，用於性和生殖方面的研究。

根據醫學建議，Aralelin可以提高男性睪固酮水平，治療女性子宮內膜異位症，增強腦下垂體產生更多LH和FSH，幫助減輕老化症狀，並幫助解決生殖問題。Aralelin 被批准用於兔子陰道內給藥，以在人工授精期間誘導排卵，劑量高達 50 克/隻。

Aralelin全球市場概況

子宮內膜異位症盛行率的上升和醫療保健研究的增加正在推動 Ararelin 市場向前發展。子宮內膜異位症常見於接受輸卵管絕育術並已證明具有生育能力的女性。一般人群中子宮內膜異位症的確切發生率尚不清楚。盛行率估計是基於患病可能性較高的手術族群。此外，男性的睪固酮水平有所增加。這種藥物易於使用，可治療女性子宮內膜異位症。增加腦下垂體產生 LH 和 FSH。此外，與其他勝肽一樣，Aralelin 可以減輕老化症狀。解決女性生殖問題的最佳方法將推動預測期內全球 Ararelin 市場的整體成長。

Ararelin 的使用有一些副作用，還會引起其他健康併發症，這可能會限制市場成長。Ararelin 的副作用包括口乾、關節問題、過量服用導致的過多水分滯留、注射部位周圍皮膚疼痛或發癢、飢餓感增加以及體重減輕或增加。此外，廣泛的頭痛、腎痛、感覺喪失和血壓過高正在阻礙全球 Ararelin 市場的整體成長。此外，COVID-19 大流行將擾亂生產。由於國家停工、邊境關閉以及嚴格的社會試錯措施導致市場成長受阻，Ararelin 遭受了巨大損失。

Alarelin Market size was valued at USD 2.6 Billion in 2024 and is projected to reach USD 5.7 Billion by 2031, growing at a CAGR of 4.4 % during the forecast period 2024-2031. Alarelin is mainly used in clinical research to evaluate the drug's effects on an animal's body in reproductive and sexual kinds of research. The rise in the prevalence of endometriosis, combined with growing healthcare research, is boosting the Alarelin Market forward. The use of alarelin can have some adverse effects or cause other medical complications, which may inhibit the market growth. Over the forecasted period. The Global Alarelin Market report provides a holistic evaluation of the market. The report comprehensively analyzes key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Alarelin Market Definition

Alarelin, also known as gonadotropin, is a releasing hormone. It is a synthetic LH-RH agonist present in higher concentrations than LH-RH in vitro, in vivo, and in ovulation inductions. It is a type of medication that is commonly used to treat endometriosis or hysteromyoma. Alarelin is primarily used in clinical research to study the drug's effects on an animal's body for circumstances related to sexual and reproductive research.

With a medical recommendation, alarelin enhances testosterone levels in men, treats endometriosis in women, enhances the pituitary gland to generate more LH and FSH, aids in the reduction of aging symptoms, and resolves reproduction issues in women. Alarelin is approved for use in rabbits for intravaginal administration to induce ovulation during artificial insemination at doses of up to 50 g/doe.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Alarelin Market Overview

The rising prevalence of endometriosis, combined with growing healthcare research, is propelling the Alarelin Market forward. Endometriosis is found in females enduring tubal sterilization procedures who have demonstrated fertility. The exact incidence of endometriosis in the general population is uncertain. Prevalence estimates are based on a surgical population with a high probability of disease. Moreover, Men's testosterone levels increased. The medication is simple to use and treats female Endometriosis. Increases the production of LH and FSH by the pituitary gland. Furthermore, Alarelin, like other peptides, enables the reduction of aging symptoms. The best approach for female reproduction concerns leading to driving the overall growth of the Global Alarelin Market throughout the projected period.

Alarelin use has some adverse side effects or leads to other health complications, which may limit the market growth. Some of the side effects of alarelin include dry mouth, joint problems, excessive water retention caused by overdosing, pains or itchy skin around the site of injection, increased hunger, as well as weight loss/gain. Furthermore, Extensive headaches, Kidney pain, Loss of sensation, and Blood pressure are too high leading to inhibiting the overall growth of the Global Alarelin Market. Furthermore, The COVID-19 pandemic disrupts production. Alarelin has suffered significantly as a result of national lockdowns, border crossing seals, and rigid social trying-to-distance measures leading to hindering the growth of the market.

Global Alarelin Market Segmentation Analysis

The Global Alarelin Market is Segmented Based on Type, Applications, And Geography.

Alarelin Market, By Type

Alarelin 98%
Alarelin 99%
Other
Based on Type, The market is classified into Alarelin 98%, Alarelin 99%, and Other. The Alarelin 98% has the highest growing segment of the Global Alarelin Market. Alarelin is used to treat endometriosis and may stimulate ovulation. It is in charge of the pituitary gland's secretion of gonadotropins, luteinizing hormone, and follicle-stimulating hormone

Alarelin Market, By Application

Uterine Fibroids
Endometriosis
Others

Based on Applications, The market is classified into Uterine Fibroids, Endometriosis, and Others. Uterine Fibroids have the highest-growing segment of the Global Alarelin Market. Uterine fibroids are noncancerous uterine lesions that most commonly appear during pregnancy. Uterine fibroids, also known as leiomyomas or myomas, are not linked with an increased incidence of uterine cancer and also never increase the risk of cancer Endometriosis is a painful disorder in which tissue similar to the endometrium, which generally lines the inside uterus, starts growing outside the uterus.

Alarelin Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Alarelin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the largest growing segment of the Alarelin Market. North America and Europe have the largest growing segment of the Global Alarelin Market throughout the forecasted period.

Key Players

The "Global Alarelin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
Hangzhou Longshine Bio-Tech, Rixing Chemical CO., LTD, Santa Cruz Biotechnology, JSN Chemicals, Chemwill Asia Co, BBCA Group, ALB Technology Limited, LGM Pharma Ltd., Henan Tianfu Chemical Co., Ltd., And Shanghai Soho-Yiming Pharmaceuticals.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1. INTRODUCTION OF GLOBAL ALARELIN MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL ALARELIN MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5. GLOBAL ALARELIN MARKET, BY TYPE

5.1. Overview
5.2. Alarelin 98%
5.3. Alarelin 99%
5.4. Others

6 GLOBAL ALARELIN MARKET, BY APPLICATION

6.1 Overview
6.2 Uterine Fibroids
6.3 Endometriosis
6.4 Other

7 GLOBAL ALARELIN MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.3 Canada
- 7.2.4 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL ALARELIN COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9. COMPANY PROFILES

9.1 Hangzhou Longshine Bio-Tech
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Rixing Chemical CO.LTD
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Santa Cruz Biotechnology
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 JSN Chemicals
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Chemwill Asia Co
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 ALB Technology Limited
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 LGM PharmaLtd
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 BBCA Group
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments